What is Vertex Pharmaceuticals's indefinite- lived intangible impairment?

Vertex Pharmaceuticals (VRTX) reported indefinite- lived intangible impairment of $470.30M in Q1 2026.

How has Vertex Pharmaceuticals's indefinite- lived intangible impairment changed year-over-year?

Vertex Pharmaceuticals's indefinite- lived intangible impairment decreased by 0.0% year-over-year, from $470.30M to $470.30M.

What does indefinite- lived intangible impairment mean?

The total value of non-goodwill intangible assets that have been written down due to a loss in value.

Other

Indefinite- lived intangible impairment

Vertex Pharmaceuticals Indefinite- lived intangible impairment remained flat by 0.0% to $470.30M in Q1 2026 compared to the prior quarter. Year-over-year, this metric was flat by 0.0%, from $470.30M to $470.30M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementBalance Sheet Statement

SectionOther

CategoryProfitability

SignalLower is better

VolatilityVolatile

First reportedQ4 2024

Last reportedQ1 2026May 5, 2026

How to read this metric

An increase in impairment charges signals a decline in the value of the company's intangible assets, potentially indicating poor acquisition outcomes or changing market conditions.

Detailed definition

This represents the gross value of indefinite-lived intangible assets, excluding goodwill, that have been subject to imp...

Peer comparison

Varies significantly based on M&A history; companies with frequent acquisitions often show higher volatility in this metric.

Metric ID: other_intangible_assets_gross_excluding_goodwill

Historical Data

6 periods

	Q4 '24	Q1 '25	Q2 '25	Q3 '25	Q4 '25	Q1 '26
Value	$849.30M	$470.30M	$470.30M	$470.30M	$470.30M	$470.30M
QoQ Change	—	-44.6%	+0.0%	+0.0%	+0.0%	+0.0%
YoY Change	—	—	—	—	-44.6%	+0.0%

Range$470.30M – $849.30M

CAGR-37.7%

Avg YoY Growth-22.3%

Median YoY Growth-22.3%

Current Streak4 quarters growth

Indefinite- lived intangible impairment at Other Companies

AbbVieABBV View metric

Merck & Co.MRK View metric

ViatrisVTRS View metric

PfizerPFE View metric

Frequently Asked Questions

What is Vertex Pharmaceuticals's indefinite- lived intangible impairment?: Vertex Pharmaceuticals (VRTX) reported indefinite- lived intangible impairment of $470.30M in Q1 2026.
How has Vertex Pharmaceuticals's indefinite- lived intangible impairment changed year-over-year?: Vertex Pharmaceuticals's indefinite- lived intangible impairment decreased by 0.0% year-over-year, from $470.30M to $470.30M.
What does indefinite- lived intangible impairment mean?: The total value of non-goodwill intangible assets that have been written down due to a loss in value.